AstraZeneca boosts cancer portfolio with $320 mln Neogene deal
AstraZeneca (AZN.L) will acquire biotechnology company Neogene Therapeutics for up to $320 million,
EU regulator backs wider use of AstraZeneca COVID therapy
Europe’s medicines regulator has backed using AstraZeneca’s preventative COVID-19 therapy as a
Japan panel approves AstraZeneca’s Evusheld COVID treatment
Japan’s health ministry said on Monday that its panel of experts had agreed to approve manufacturing
AstraZeneca’s Farxiga cuts death risk in heart failure patients -study
AstraZeneca’s (AZN.L) blockbuster diabetes drug Farxiga led to significant reductions in the risk of
AstraZeneca lifts revenue guidance on COVID treatment
AstraZeneca (AZN.L) said it expected prescriptions of its COVID therapy to drive sales growth of
AstraZeneca gets EU backing for targeted breast cancer therapies
AstraZeneca (AZN.L) said on Monday two of its existing therapies were recommended for treating
New data sets stage for broader use of AstraZeneca breast cancer drug
AstraZeneca (AZN.L) and Daiichi Sankyo’s (4568.T) Enhertu extended survival by more than six months
Britain approves AstraZeneca’s preventative COVID therapy
Britain’s medicines regulator has approved AstraZeneca’s antibody-based COVID-19 treatment for
AstraZeneca boosts oncology credentials with breast cancer trial success
AstraZeneca says its Enhertu cancer drug has been shown to significantly help women suffering from a
London stocks rise on potential Biden-Putin summit
United Kingdom shares tracked global markets higher on Monday, as hopes of a de-escalation in
Short AstraZeneca shelf life complicates COVID vaccine rollout to world’s poorest
The relatively short shelf life of AstraZeneca Plc’s COVID-19 vaccine is complicating the rollout to
Easing curbs in ‘COVID-zero regions’ could cause 2 million deaths in a year – China study
Restoring normal population mobility to “COVID-zero regions’” like China will cause some 2 million
Easing curbs in 'COVID-zero regions' could cause 2 million deaths in a year – China study
Restoring normal population mobility to “COVID-zero regions’” like China will cause some 2 million
EMA lists rare spinal condition as side effect of AstraZeneca’s COVID-19 shot
A safety panel of the European drug regulator on Friday recommended adding a rare spinal
AstraZeneca vaccine booster shot effective against Omicron: Oxford lab study
A three-dose course of AstraZeneca’s COVID-19 vaccine is effective against the Omicron coronavirus
AstraZeneca drug cocktail succeeds in late-stage study to treat COVID-19
AstraZeneca’s experimental COVID-19 antibody drug cocktail succeeded in reducing severe disease or
Small-scale study shows antibody growth from AstraZeneca, Sputnik Light COVID-19 vaccine mix
A small-scale clinical study of the combined use of the AstraZeneca and Sputnik Light vaccines
African countries receive COVID-19 vaccines from Canada, US
Canada has donated more than 1.3 million doses of AstraZeneca’s COVID-19 vaccine to three African
African Union wants Covishield approved for EU COVID-19 certificate
The African Union has criticised an EU decision not to include Covishield, a version of
Another rare blood condition identified as potential side effect of AstraZeneca vaccine
Europe’s drug regulator says it has identified another rare blood condition as a potential side